Béatrice Ané

Béatrice Ané has extensive experience in the pharmaceutical industry, with a focus on rare diseases, neurology, cardiology, and psychiatry. Currently serving as Responsable Parcours de Soin Territorial Maladies Rares at Alexion Pharmaceuticals, Inc. since October 2022, Béatrice has been with Recordati Rare Diseases Inc. since 2015 as Responsable régionale scientifique. Previous roles include Déléguée hospitalière at Boehringer Ingelheim (2005-2015), where expertise in cardiology and neurology was developed, and at Merck Serono (1999-2003), focusing on neurology and successful product launches. Earlier positions at Lundbeck and Eli Lilly and Company specialized in psychiatry and involved significant product promotion and network creation. Béatrice holds a Bac +4 degree in Action commerciale européenne from ESG Paris and a DEESMI in international marketing from ISEG Nantes.